非血栓性髂静脉病变支架置入后是否有必要行球囊扩张?
本研究纳入71例非血栓性髂静脉病变(NIVLs)患者,在支架置入后行球囊扩张,用血管内超声测量狭窄段、支架置入后及球囊扩张后的面积。
要点
- 球囊扩张未显示临床或技术获益,应仅用于支架自膨胀不充分时。
- 30天内1例出现管腔内部分血栓。
核心结论
- 在NIVLs中,支架置入后行球囊扩张未显示显著的临床或技术获益。
- 支架置入后球囊扩张应仅限于荧光透视下支架自膨胀不充分的病例。
研究设计与样本
- 单中心前瞻性研究,6个月内完成71例髂静脉球囊扩张联合支架置入(右34肢、左37肢)。
- 术中使用血管内超声测量髂股静脉面积,狭窄>50%横截面积或直径缩减时置入支架(直径12-24 mm,长度40-90 mm)并球囊扩张(10×40 mm至16×60 mm)。
主要发现
- 狭窄病变平均面积99.06 mm²(范围28-318 mm²,标准差±45.87 mm²)。
- 支架置入后平均面积151.51 mm²(范围28-303 mm²,标准差±55.82 mm²)。
- 面积差异与年龄、临床分级(C2-C6)、性别、病变、侧别及靶病变位置无统计学显著相关性。
- 1例患者在干预后30天内出现管腔内部分血栓。
关键数值与推荐
- 狭窄>50%横截面积或直径缩减时置入支架。
- 支架直径12-24 mm,长度40-90 mm;球囊尺寸10×40 mm至16×60 mm。
临床怎么用
- 在NIVLs支架置入后,不推荐常规行球囊扩张。
- 仅在荧光透视下支架自膨胀不充分时考虑球囊扩张。
局限性
- 随访时间短(30天内血栓事件)。
- 单中心初步数据,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Iliac vein stenting is an evolving treatment option for chronic venous insufficiency and management of nonthrombotic iliac vein lesions (NIVLs). Currently described protocols recommend deployed stents to be dilated with balloon venoplasty before completion of the procedure, based on previous literature established from management of arterial lesions. The objective of the study was to investigate the role of balloon venoplasty after stent deployment in the management of NIVLs. METHODS: During the course of 6 months, 71 balloon venoplasties with stenting of iliac veins (34 right and 37 left limbs) were performed. Intraoperatively, we used intravascular ultrasound to measure and to record area of iliofemoral veins. The measurement of stenosis was compared with adjacent nonstenotic iliofemoral veins. If >50% cross-sectional area or diameter reduction was found, it was treated with an appropriate balloon size (range, 10 × 40 mm to 16 × 60 mm) and Wallstent (Boston Scientific, Natick, Mass; 12-24 mm in diameter by 40-90 in mm length). All stents were dilated with a balloon after deployment. Intravascular ultrasound was used to measure the preoperative area of stenotic lesion, area of lesion after stenting, and area after balloon dilation of the stent. RESULTS: The mean age of the patients was 65.34 years (range, 36-99 years; standard deviation [SD], ±13.52 years), with 27 female and 20 male patients. The location of the targeted stenosis was the common iliac vein (31), external iliac vein (36), and common femoral vein (4). The mean area of the stenotic lesion was 99.06 mm2 (range, 28-318 mm2; SD, ±45.87 mm2). The mean area after stenting was 151.51 mm2 (range, 28-303 mm2; SD, ±55.82 mm2). The mean area after dilation of the stent was 162.72 mm2 (range, 86-367 mm2; SD, ±51.94 mm2; P = .22). No statistically significant correlation was found between difference in areas and age of the patient, clinical class (C2-C6), sex, lesion, laterality, and location of targeted lesion. One patient developed an intraluminal partial thrombus within 30 days of intervention. CONCLUSIONS: Our preliminary data show no significant clinical or technical benefit with use of balloon venoplasty to dilate stents after deployment in NIVLs. Postdilation should thus be limited to only those with suboptimal self-expansion of stent after initial deployment on fluoroscopic imaging.
引用
- Aurshina A, Ostrozhynskyy Y, Nguyen H, et al. Is it necessary to dilate stents in management of nonthrombotic iliac vein lesions? J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31203858. doi:10.1016/j.jvsv.2018.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。